(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODO PARA ENRIQUECER LINFÓCITOS INFILTRANTES DE TUMOR REATIVOS A TUMOR, E, COMPOSIÇÃO FARMACÊUTICA

Em AnáliseInvention PatentPCT · US2023080154

Application data

Number

112025010101

Type

Invention Patent

Filing

11/16/2023

Publication

01/06/2026

PCT

US2023080154

Progress at the INPI

Examination not yet requested
  1. Filing11/16/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 11/16/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:11/16/2026(83 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IOVANCE BIOTHERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

M. S. (pessoa física)

US

Technical data

Priority claims

US

63/384,576 · 11/21/2022

Abstract

MÉTODO PARA ENRIQUECER LINFÓCITOS INFILTRANTES DE TUMOR REATIVOS A TUMOR, E, COMPOSIÇÃO FARMACÊUTICA. São aqui providos métodos para a produção de LITs por meio de (i) etapas de expansão pré-REP, (ii) cocultura com células dendríticas apresentando antígenos específicos de tumor, (iii) cocultura com organoides derivados de tumor, (iv) seleção de LITs reativos a tumor e (v) expansão rápida dos ditos LITs reativos a tumor, ou combinações destes. A terapêutica e o diagnóstico resultantes são igualmente descritos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

01/06/2026

RPI 2870

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.